National
An Indian Drug Company Glenmark launches COVID-19 drug after Drugs Controller General of India nod
FabiFlu is the first oral Favipiravir-approved medication for the treatment of COVID-19, the company said in a statement. The drug will be available as a prescription-based medication for Rs 103/tablet, with recommended dose being 1,800 mg twice on day one, followed by 800 mg twice daily up to